Aicardi–Goutières syndrome and the type I interferonopathies (original) (raw)

• Gresser, I. et al. Interferon-induced disease in mice and rats. Ann. NY Acad. Sci. 350, 12–20 (1980). A summary of the first experimental data indicating that high levels of IFN might be detrimental in mammals.
  CAS PubMed Google Scholar
• Aicardi, J. & Goutières, F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann. Neurol. 15, 49–54 (1984).
  CAS PubMed Google Scholar
• Lebon, P. et al. Intrathecal synthesis of interferon-α in infants with progressive familial encephalopathy. J. Neurol. Sci. 84, 201–208 (1988).
  CAS PubMed Google Scholar
• Crow, Y. J. et al. Cree encephalitis is allelic with Aicardi–Goutières syndrome: implications for the pathogenesis of disorders of interferon α metabolism. J. Med. Genet. 40, 183–187 (2003).
  CAS PubMed PubMed Central Google Scholar
• Crow, Y. J. et al. Mutations in the gene encoding the 3′–5′ DNA exonuclease TREX1 cause Aicardi–Goutières syndrome at the AGS1 locus. Nat. Genet. 38, 917–920 (2006).
  CAS PubMed Google Scholar
• Crow, Y. J. et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi–Goutières syndrome and mimic congenital viral brain infection. Nat. Genet. 38, 910–916 (2006).
  CAS PubMed Google Scholar
• Rice, G. I. et al. Mutations involved in Aicardi–Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 41, 829–832 (2009).
  CAS PubMed PubMed Central Google Scholar
• Rice, G. I. et al. Mutations in ADAR1 cause Aicardi–Goutières syndrome associated with a type I interferon signature. Nat. Genet. 44, 1243–1248 (2012).
  CAS PubMed PubMed Central Google Scholar
• Rice, G. I. et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat. Genet. 46, 503–509 (2014). This paper is the first to describe mutations in a cytoplasmic nucleic acid receptor.
  CAS PubMed PubMed Central Google Scholar
• Crow, Y. J. et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am. J. Med. Genet. A 167A, 296–312 (2015).
  PubMed Google Scholar
• Tolmie, J. L., Shillito, P., Hughes-Benzie, R. & Stephenson, J. B. The Aicardi–Goutières syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis). J. Med. Genet. 32, 881–884 (1995).
  CAS PubMed PubMed Central Google Scholar
• Crow, Y. J. et al. Congenital glaucoma and brain stem atrophy as features of Aicardi–Goutières syndrome. Am. J. Med. Genet. A 129A, 303–307 (2004).
  PubMed Google Scholar
• Dale, R. C., Tang, S. P., Heckmatt, J. Z. & Tatnall, F. M. Familial systemic lupus erythematosus and congenital infection-like syndrome. Neuropediatrics 31, 155–158 (2000).
  CAS PubMed Google Scholar
• Crow, Y. J. Type I interferonopathies: a novel set of inborn errors of immunity. Ann. NY Acad. Sci. 1238, 91–98 (2011). This is the first paper to use the term type I interferonopathy.
  CAS PubMed Google Scholar
• Crow, Y. J. Type I interferonopathies: Mendelian type I interferon up-regulation. Curr. Opin. Immunol. 32, 7–12 (2014).
  PubMed Google Scholar
• Kaneko, H. et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 471, 325–330 (2011).
  CAS PubMed PubMed Central Google Scholar
• Tarallo, V. et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149, 847–859 (2012).
  CAS PubMed PubMed Central Google Scholar
• Rice, G. I. et al. Assessment of interferon-related biomarkers in Aicardi–Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol. 12, 1159–1169 (2013). A comprehensive description of the type I IFN signature in association with mutations in AGS-related genes.
  CAS PubMed PubMed Central Google Scholar
• Akwa, Y. et al. Transgenic expression of IFN-α in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J. Immunol. 161, 5016–5026 (1998). This paper demonstrates the neuronal toxicity of type I IFN expression in mice.
  CAS PubMed Google Scholar
• Krivine, A., Tovey, M., Taty-Taty, R. & Lebon, P. Endogenous interferon-α in newborns from HIV seropositive mothers. J. Interferon Res. 12, S151 (1992).
  Google Scholar
• Kauffman, W. M. et al. CT and MR evaluation of intracranial involvement in pediatric HIV infection: a clinical-imaging correlation. AJNR Am. J. Neuroradiol. 13, 949–957 (1992).
  CAS PubMed Google Scholar
• DeCarli, C., Civitello, L. A., Brouwers, P. & Pizzo, P. A. The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus. Ann. Neurol. 34, 198–205 (1993).
  CAS PubMed Google Scholar
• Tardieu, M. et al. HIV-1-related encephalopathy in infants compared with children and adults. Neurology 54, 1089–1095 (2000).
  CAS PubMed Google Scholar
• Bessis, D. et al. Necrotizing cutaneous lesions complicating treatment with pegylated-interferon alfa in an HIV-infected patient. Eur. J. Dermatol. 12, 99–102 (2002).
  PubMed Google Scholar
• Ronnblom, L. E., Alm, G. V. & Oberg, K. E. Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour. J. Intern. Med. 227, 207–210 (1990).
  CAS PubMed Google Scholar
• Kwon, Y. S., Choe, Y. H. & Chin, H. S. Development of glaucoma in the course of interferon α therapy for chronic hepatitis B. Yonsei Med. J. 42, 134–136 (2001).
  CAS PubMed Google Scholar
• Crow, Y. J. & Rehwinkel, J. Aicardi–Goutières syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum. Mol. Genet. 18, R130–R136 (2009).
  CAS PubMed PubMed Central Google Scholar
• Stetson, D. B., Ko, J. S., Heidmann, T. & Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587–598 (2008). This paper is the first to describe TREX1 as a possible regulator of cytoplasmic DNA derived from retroelements.
  CAS PubMed PubMed Central Google Scholar
• Gall, A. et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36, 120–131 (2012).
  CAS PubMed PubMed Central Google Scholar
• Sanchis, A. et al. Genetic syndromes mimic congenital infections. J. Pediatr. 146, 701–705 (2005).
  CAS PubMed Google Scholar
• Reijns, M. A. et al. Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell 149, 1008–1022 (2012). This paper is the first to describe the essential role of RNase H2 in removing ribonucleotides that are incorporated during DNA synthesis.
  CAS PubMed PubMed Central Google Scholar
• Hiller, B. et al. Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. J. Exp. Med. 209, 1419–1426 (2012).
  CAS PubMed PubMed Central Google Scholar
• Perrino, F. W., Harvey, S., Shaban, N. M. & Hollis, T. RNaseH2 mutants that cause Aicardi–Goutières syndrome are active nucleases. J. Mol. Med. (Berl.) 87, 25–30 (2009).
  CAS Google Scholar
• Rigby, R. E. et al. RNA:DNA hybrids are a novel molecular pattern sensed by TLR9. EMBO J. 33, 542–558 (2014).
  CAS PubMed PubMed Central Google Scholar
• Mankan, A. K. et al. Cytosolic RNA:DNA hybrids activate the cGAS–STING axis. EMBO J. 33, 2937–2946 (2014).
  CAS PubMed PubMed Central Google Scholar
• Rehwinkel, J. et al. SAMHD1-dependent retroviral control and escape in mice. EMBO J. 32, 2454–2462 (2013).
  CAS PubMed PubMed Central Google Scholar
• Behrendt, R. et al. Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response. Cell Rep. 4, 689–696 (2013).
  CAS PubMed PubMed Central Google Scholar
• Goldstone, D. C. et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480, 379–382 (2011).
  CAS PubMed Google Scholar
• Laguette, N. et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654–657 (2011). This paper, together with reference 58, is the first to describe SAMHD1 as an HIV-1 restriction factor.
  CAS PubMed PubMed Central Google Scholar
• Ryoo, J. et al. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat. Med. 20, 936–941 (2014).
  CAS PubMed PubMed Central Google Scholar
• Hartner, J. C., Walkley, C. R., Lu, J. & Orkin, S. H. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat. Immunol. 10, 109–115 (2009). This paper contains an important description of ADAR as a suppressor of type I IFN-induced signalling.
  CAS PubMed Google Scholar
• Mannion, N. M. et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep. 9, 1482–1494 (2014).
  CAS PubMed PubMed Central Google Scholar
• Vitali, P. & Scadden, A. D. Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis. Nat. Struct. Mol. Biol. 17, 1043–1050 (2010).
  CAS PubMed PubMed Central Google Scholar
• Funabiki, M. et al. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 40, 199–212 (2014).
  CAS PubMed Google Scholar
• Oda, H. et al. Aicardi–Goutières syndrome is caused by IFIH1 mutations. Am. J. Hum. Genet. 95, 121–125 (2014).
  CAS PubMed PubMed Central Google Scholar
• Yang, Y. G., Lindahl, T. & Barnes, D. E. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131, 873–886 (2007). This report is the first to suggest a link between TREX1 and the DNA damage response.
  CAS PubMed Google Scholar
• Pizzi, S. et al. Reduction of hRNase H2 activity in Aicardi–Goutières syndrome cells leads to replication stress and genome instability. Hum. Mol. Genet. 24, 649–658 (2014).
  PubMed PubMed Central Google Scholar
• Kind, B. et al. Altered spatio-temporal dynamics of RNase H2 complex assembly at replication and repair sites in Aicardi–Goutières syndrome. Hum. Mol. Genet. 23, 5950–5960 (2014).
  CAS PubMed Google Scholar
• Gunther, C. et al. Defective removal of ribonucleotides from DNA promotes systemic autoimmunity. J. Clin. Invest. 125, 413–424 (2014).
  PubMed PubMed Central Google Scholar
• Kretschmer, S. et al. SAMHD1 prevents autoimmunity by maintaining genome stability. Ann. Rheum. Dis. 74, e17 (2014).
  PubMed PubMed Central Google Scholar
• Clifford, R. et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood 123, 1021–1031 (2014).
  CAS PubMed PubMed Central Google Scholar
• Landau, D. A. et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152, 714–726 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ferguson, B. J., Mansur, D. S., Peters, N. E., Ren, H. & Smith, G. L. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. eLife 1, e00047 (2012).
  PubMed PubMed Central Google Scholar
• Laguette, N. et al. Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell 156, 134–145 (2014).
  CAS PubMed Google Scholar
• Hartlova, A. et al. DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity. Immunity 42, 332–343 (2015).
  PubMed Google Scholar
• Brooks, P. J., Cheng, T. F. & Cooper, L. Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage? DNA Repair (Amst.) 7, 834–848 (2008).
  CAS Google Scholar
• Yan, N., Regalado-Magdos, A. D., Stiggelbout, B., Lee-Kirsch, M. A. & Lieberman, J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 11, 1005–1013 (2010). This paper is the first to describe a role for TREX1 in HIV-1 metabolism.
  CAS PubMed PubMed Central Google Scholar
• Hrecka, K. et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658–661 (2011). This paper, together with reference 39, is the first to describe SAMHD1 as an HIV-1 restriction factor.
  CAS PubMed PubMed Central Google Scholar
• Manel, N. et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467, 214–217 (2010).
  CAS PubMed PubMed Central Google Scholar
• Lahaye, X. et al. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 39, 1132–1142 (2013).
  CAS PubMed Google Scholar
• Zhao, K. et al. Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi–Goutières syndrome-related SAMHD1. Cell Rep. 4, 1108–1115 (2013).
  CAS PubMed PubMed Central Google Scholar
• Genovesio, A. et al. Automated genome-wide visual profiling of cellular proteins involved in HIV infection. J. Biomol. Screen. 16, 945–958 (2011).
  CAS PubMed Google Scholar
• Volkman, H. E. & Stetson, D. B. The enemy within: endogenous retroelements and autoimmune disease. Nat. Immunol. 15, 415–422 (2014).
  CAS PubMed PubMed Central Google Scholar
• Zeng, M. et al. MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses. Science 346, 1486–1492 (2014).
  CAS PubMed PubMed Central Google Scholar
• Gorbunova, V., Boeke, J. D., Helfand, S. L. & Sedivy, J. M. Human genomics. Sleeping dogs of the genome. Science 346, 1187–1188 (2014).
  CAS PubMed PubMed Central Google Scholar
• Yu, Q. et al. Type I interferon controls propagation of long interspersed element-1. J. Biol. Chem. 290, 10191–10199 (2015).
  CAS PubMed PubMed Central Google Scholar
• Beck-Engeser, G. B., Eilat, D. & Wabl, M. An autoimmune disease prevented by anti-retroviral drugs. Retrovirology 8, 91 (2011). This paper is the first to report the successful use of reverse transcriptase inhibitors in Trex1 -null mice.
  CAS PubMed PubMed Central Google Scholar
• Hooks, J. J. et al. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301, 5–8 (1979).
  CAS PubMed Google Scholar
• Lee-Kirsch, M. A. et al. Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. Am. J. Hum. Genet. 79, 731–737 (2006).
  CAS PubMed PubMed Central Google Scholar
• Ravenscroft, J. C., Suri, M., Rice, G. I., Szynkiewicz, M. & Crow, Y. J. Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. Am. J. Med. Genet. A 155A, 235–237 (2011).
  PubMed Google Scholar
• Briggs, T. A. et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat. Genet. 43, 127–131 (2011).
  CAS PubMed Google Scholar
• Lee-Kirsch, M. A. et al. Mutations in the gene encoding the 3′–5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39, 1065–1067 (2007).
  CAS PubMed Google Scholar
• Ellyard, J. I. et al. Identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by whole-exome sequencing. Arthritis Rheuml. 66, 3382–3386 (2014).
  CAS Google Scholar
• Troedson, C. et al. Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy. Lupus 22, 639–643 (2013).
  CAS PubMed Google Scholar
• Arkwright, P. D., Riley, P., Hughes, S. M., Alachkar, H. & Wynn, R. F. Successful cure of C1q deficiency in human subjects treated with hematopoietic stem cell transplantation. J. Allergy Clin. Immunol. 133, 265–267 (2014).
  CAS PubMed Google Scholar
• Lood, C. et al. C1q inhibits immune complex-induced interferon-α production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum. 60, 3081–3090 (2009).
  CAS PubMed Google Scholar
• Santer, D. M. et al. C1q deficiency leads to the defective suppression of IFN-α in response to nucleoprotein containing immune complexes. J. Immunol. 185, 4738–4749 (2010).
  CAS PubMed PubMed Central Google Scholar
• Liu, Y. et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 371, 507–518 (2014). This paper is the first to describe TMEM173 mutations in a type I interferonopathy phenotype.
  CAS PubMed PubMed Central Google Scholar
• Jeremiah, N. et al. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J. Clin. Invest. 124, 5516–5520 (2014).
  PubMed PubMed Central Google Scholar
• Ahn, J., Ruiz, P. & Barber, G. N. Intrinsic self-DNA triggers inflammatory disease dependent on STING. J. Immunol. 193, 4634–4642 (2014).
  CAS PubMed PubMed Central Google Scholar
• Rutsch, F. et al. A specific IFIH1 gain-of-function mutation causes Singleton–Merten syndrome. Am. J. Hum. Genet. 96, 275–282 (2015).
  CAS PubMed PubMed Central Google Scholar
• Goubau, D. et al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates. Nature 514, 372–375 (2014).
  CAS PubMed PubMed Central Google Scholar
• Jang, M. A. et al. Mutations in DDX58, which encodes RIG-I, cause atypical Singleton–Merten syndrome. Am. J. Hum. Genet. 96, 266–274 (2015). This paper is the first to describe mutations in the gene encoding RIG-I as a cause of type I IFN upregulation in humans.
  CAS PubMed PubMed Central Google Scholar
• Zhang, X. et al. Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. Nature 517, 89–93 (2015). This paper describes ISG15 mutations as a cause of a human type I interferonopathy.
  CAS PubMed Google Scholar
• Bogunovic, D. et al. Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science 337, 1684–1688 (2012).
  CAS PubMed PubMed Central Google Scholar
• Francois-Newton, V. et al. USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response. PLoS ONE 6, e22200 (2011).
  CAS PubMed PubMed Central Google Scholar
• Agarwal, A. K. et al. PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am. J. Hum. Genet. 87, 866–872 (2010).
  CAS PubMed PubMed Central Google Scholar
• Liu, Y. et al. Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum. 64, 895–907 (2012).
  CAS PubMed PubMed Central Google Scholar
• Moebius, J., van den Broek, M., Groettrup, M. & Basler, M. Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice. Eur. J. Immunol. 40, 3439–3449 (2010).
  CAS PubMed Google Scholar
• Ramesh, V. et al. Intracerebral large artery disease in Aicardi–Goutières syndrome implicates SAMHD1 in vascular homeostasis. Dev. Med. Child Neurol. 52, 725–732 (2010).
  PubMed Google Scholar
• Livingston, J. H. et al. A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1. J. Med. Genet. 51, 76–82 (2014).
  CAS PubMed Google Scholar
• Vogt, J. et al. Striking intrafamilial phenotypic variability in Aicardi–Goutières syndrome associated with the recurrent Asian founder mutation in RNASEH2C. Am. J. Med. Genet. A 161A, 338–342 (2013).
  PubMed Google Scholar
• Ramantani, G. et al. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi–Goutières syndrome. Arthritis Rheum. 62, 1469–1477 (2010).
  CAS PubMed Google Scholar
• Van Eyck, L. et al. IFIH1 mutation causes systemic lupus erythematosus with selective IgA-deficiency. Arthritis Rheuml. http://dx.doi.org/10.1002/art.39110 (2015).
• Rice, G. et al. Clinical and molecular phenotype of Aicardi–Goutières syndrome. Am. J. Hum. Genet. 81, 713–725 (2007).
  CAS PubMed PubMed Central Google Scholar
• Lausch, E. et al. Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat. Genet. 43, 132–137 (2011).
  CAS PubMed Google Scholar
• McGonagle, D. & McDermott, M. F. A proposed classification of the immunological diseases. PLoS Med. 3, e297 (2006).
  PubMed PubMed Central Google Scholar
• Eckard, S. C. et al. The SKIV2L RNA exosome limits activation of the RIG-I-like receptors. Nat. Immunol. 15, 839–845 (2014).
  CAS PubMed PubMed Central Google Scholar
• White, M. J. et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 159, 1549–1562 (2014).
  CAS PubMed PubMed Central Google Scholar
• West, A. P. et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature http://dx.doi.org/10.1038/nature14156 (2015).
• Niewold, T. B., Hua, J., Lehman, T. J., Harley, J. B. & Crow, M. K. High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 8, 492–502 (2007).
  CAS PubMed PubMed Central Google Scholar
• Schoggins, J. W. Interferon-stimulated genes: roles in viral pathogenesis. Curr. Opin. Virol. 6, 40–46 (2014).
  CAS PubMed Google Scholar
• Takanohashi, A. et al. Elevation of proinflammatory cytokines in patients with Aicardi–Goutières syndrome. Neurology 80, 997–1002 (2013).
  CAS PubMed PubMed Central Google Scholar
• Cuadrado, E. et al. Aicardi–Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2014-205396 (2014).
• Crow, Y. J., Vanderver, A., Orcesi, S., Kuijpers, T. W. & Rice, G. I. Therapies in Aicardi–Goutières syndrome. Clin. Exp. Immunol. 175, 1–8 (2014).
  CAS PubMed Google Scholar
• Gehrke, N. et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 39, 482–495 (2013).
  CAS PubMed Google Scholar